Expectations and Concerns Towards New Extended Half-Life (EHL) Products - Results of Surveys Among Haemophilia Patients from the Dach Region

被引：0

作者：

von Mackensen, Sylvia ^{[1
]}

Kalnins, Werner ^{[2
]}

Lino, Hostettler ^{[3
]}

Joerg, Krucker ^{[3
]}

Albisetti, Manuela ^{[4
,5
]}

Weiss, Josef ^{[6
]}

Pabinger, Ingrid ^{[7
]}

Oldenburg, Johannes ^{[8
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Inst Med Psychol, Hamburg-Eppendorf, Germany

[2] German Haemophilia Soc DHG, Hamburg, Germany

[3] Swiss Hemophilia Assoc SHG, Altstatten, Switzerland

[4] Swiss Hemophilia Network SHN, Zurich, Switzerland

[5] Univ Childrens Hosp, Dept Hematol, Zurich, Switzerland

[6] Austrian Hemophilia Soc OHG, Vienna, Austria

[7] Med Univ Vienna, Dept Med I, Vienna, Austria

[8] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 46 条

[21] Real World Analysis of Coagulation Factor IX Utilization and Costs in Hemophilia B Patients Switching From Standard Half-Life To Extended Half-Life Products
Tortella, B. J.
Fogarty, P. F.
Alvir, J.
Mcdonald, M.
Spurden, D.
Pleil, A. M.
HAEMOPHILIA, 2017, 23 : 41 - 42
[22] Measuring the impact of changing from standard half-life (SHL) to extended half-life (EHL) FVIII prophylaxis on health-related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO-KLAT tool
Carcao, Manuel
Zunino, Laura
Young, Nancy L.
Dover, Saunya
Bouskill, Vanessa
Hilliard, Pamela
Price, Victoria E.
Blanchette, Victor S.
HAEMOPHILIA, 2020, 26 (01) : 73 - 78
[23] Real World Data Analysis of Coagulation Factor IX Costs in Specific Patients with Hemophilia B Switching from Standard Half-Life to Extended Half-Life Products
Tortella, Bartholomew J.
Fogarty, Patrick F.
Alvir, Jose
McDonald, Margaret
Spurden, Dean
Pleil, Andreas M.
BLOOD, 2016, 128 (22)
[24] Perception of Actual Factor Concentrates and Expectations Towards Future Treatment with New Long-Lasting Products - Results of a Survey Among Haemophilia Patients in Germany
von Mackensen, Sylvia
Heinrich, Struck
Kalnins, Werner
Oldenburg, Johannes
BLOOD, 2015, 126 (23)
[25] Improvement in health-related quality of life in patients with haemophilia B treated with nonacog beta pegol, a new extended half-life recombinant FIX product
Chowdary, P.
Kearney, S.
Regnault, A.
Hoxer, C. S.
Yee, D. L.
HAEMOPHILIA, 2016, 22 (04) : E267 - E274
[26] HOw Patients view Extended half-life products: Impressions from real-world experience (The HOPE study)
Khair, Kate
Pollard, Debra
Harrison, Catherine
Hook, Susan
O'Driscoll, Mike
Holland, Michael
HAEMOPHILIA, 2019, 25 (05) : 814 - 820
[27] FACTOR DISPENSATION AND EXPENDITURES IN HEMOPHILIA B PATIENTS SWITCHING FROM STANDARD HALF-LIFE TO EXTENDED HALF-LIFE RECOMBINANT FACTOR IX REPLACEMENT PRODUCTS: REAL-WORLD ANALYSIS IN JAPAN
Karumori, T.
Chhabra, A.
Alvir, J.
Fogarty, P. F.
Spurden, D.
Tortella, B. J.
Rubinstein, E.
Pleil, A.
VALUE IN HEALTH, 2018, 21 : S111 - S111
[28] Perception of Actual Factor Concentrates and Expectations Towards Future Treatment with New Long-Lasting Products - Results of a Survey Among Haemophilia Patients in Germany - Analysis of Open Questions
Kalnins, Werner
Miesbach, Wolfgang A.
von Mackensen, Sylvia
BLOOD, 2015, 126 (23)
[29] FVIII post infusion monitoring global study: Results and analysis of newer and extended half-life (EHL) FVIII products across external quality assessment programmes of ECAT, UK NEQAS BC and RCPAQAP
Williams, Anna
Meijer, Piet
Dean, Elysse
Reily-Stitt, Chris
Jennings, Ian
Kitchen, Steve
Walker, Isobel
HAEMOPHILIA, 2024, 30 : 83 - 83
[30] Long-term real-world health care comparison of expenditures and international units dispensed for haemophilia A patients switching to extended from standard half-life recombinant factor VIII products
Tortella, B. J.
Chhabra, A.
Fogarty, P.
Rubinstein, E.
Young, L.
Alvir, J.
HAEMOPHILIA, 2019, 25 : 56 - 56

← 1 2 3 4 5 →